DOVA - Dova Pharmaceuticals Inc.
Previous close
28.04
28.040 100.000%
Share volume: 0
Last Updated: Mon 11 Nov 2019 10:00:01 PM CET
Pharmaceuticals: Major:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
19%
Profitability
2%
Dept financing
50%
Liquidity
41%
Performance
22%
Sector
Health Technology
Industry
Pharmaceuticals: Major
Long-term ratios 30-Sep-2015 - 30-Sep-2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-42.46%
Return on assets
-15.99%
Return on sales
-541.21%
Return on invested capital
114.67%
Total debt ratio
45.42%
Debt ratio change over timeo
0.02%
Current Ratio
7.68%
Quick Ratio
6.74%
Cash Position Ratio
6.85%
Short-term ratios 30-Sep-2018 - 30-Sep-2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
-37.2%
Return on assets
-19.7%
Return on sales
-543.25%
Return on invested capital
116.07%
Total debt ratio
42.19%
Debt ratio change over timeo
-0.59%
Current Ratio
5.23%
Quick Ratio
4.98%
Cash Position Ratio
4.77%
Last quarter ratios 30-Sep-2019
The data are presented for the financials results of the last quarter.
Return on equity
-64.04%
Return on assets
-26.17%
Return on sales
-612.66%
Return on invested capital
157.82%
Total debt ratio
57.9%
Debt ratio change over time
-0.54%
Current Ratio
5.08%
Quick Ratio
4.77%
Cash Position Ratio
4.5%
Performance ratios (change over 4 years) 30-Sep-2015 - 30-Sep-2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-59.44%
Return on assets
-130.11%
Return on sales
-522.37%
Return on invested capital
139.26%
Total debt ratio
2.14%
Debt ratio change over time
0.02%
Current Ratio
17.98%
Quick Ratio
3.46%
Cash Position Ratio
19.27%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | DOVA | FTSV | PRNB | RARX |
---|---|---|---|---|
Return on equity | -42.46% | -19.36% | -4.04% | -14.62% |
Return on assets | -15.99% | -16.77% | -0.89% | -13.27% |
Return on sales | -541.21% | 0% | 0% | 0% |
Return on invested capital | 114.67% | 161.81% | -701.97% | 759.23% |
Profitability | 4% | 5% | 75% | 25% |
Total debt ratio | 45.42% | 15.55% | 34.11% | 9.59% |
Debt ratio change over time | 0.02% | -0.91% | -0.98% | -1% |
Dept financing | 50% | 9% | 19% | 5% |
Current Ratio | 5.23% | 7.5% | 12.43% | 20.49% |
Quick Ratio | 4.98% | 0% | 0% | 0% |
Cash Position Ratio | 4.77% | 0.96% | 2.15% | 19.85% |
Liquididy | 49% | 14% | 19% | 50% |
Short-term ratios | DOVA | FTSV | PRNB | RARX |
---|---|---|---|---|
Return on equity | -37.2% | -17.06% | -4.04% | -9.72% |
Return on assets | -19.7% | -15.33% | -3.59% | -9.49% |
Return on sales | -543.25% | 0% | 0% | 0% |
Return on invested capital | 116.07% | 148.9% | -701.97% | 2781.08% |
Profitability | 1% | 1% | 75% | 25% |
Total debt ratio | 42.19% | 14.74% | 11.92% | 6.35% |
Debt ratio change over time | -0.59% | -0.91% | -0.98% | -0.99% |
Dept financing | 50% | 9% | 7% | 4% |
Current Ratio | 5.23% | 7.5% | 12.43% | 20.49% |
Quick Ratio | 4.98% | 0% | 0% | 0% |
Cash Position Ratio | 4.77% | 0.96% | 2.15% | 19.85% |
Liquididy | 37% | 10% | 18% | 50% |